As Executive Vice President, Chief Financial Officer and Chief Business Officer at SAREPTA THERAPEUTICS INC, Sandesh Mahatme made $2,836,900 in total compensation. Of this total $459,252 was received as a salary, $220,441 was received as a bonus, $894,458 was received in stock options, $1,238,311 was ...
View Sandy Mahatme's profile on LinkedIn, the world's largest professional community. Sandy has 6 jobs listed on their profile. See the complete profile on LinkedIn and discover Sandy's connections and jobs at similar companies.
SANDY MAHATME. Executive Vice President, Chief Financial Officer and Chief Business Officer. Joan Nickerson, MBA. Vice President, Human Resources. SHAMIM RUFF. Senior Vice President, Chief Regulatory Affairs Officer. DOUGLAS INGRAM. DOUGLAS S. INGRAM. President and Chief Executive Officer. Mr. Ingram ...
07/20/17, Sandesh MahatmeEVP, CFO & CBO, 32,998, Derivative/Non-derivative trans. at $13.90 per share, 458,672. 07/20/17, Sandesh MahatmeEVP, CFO & CBO, 9,375, Derivative/Non-derivative trans. at $13.71 per share, 128,531. 07/21/ 17, David Tyronne HowtonSVP, General Counsel, 676, Derivative/Non-derivative ...
George Georgiou, 57 Director, Aeglea Biotherapeutics, Inc. Sandesh Mahatme, 51 Director, Flexion Therapeutics, Inc., Aeglea Biotherapeutics, Inc. Armen B. Shanafelt, 57 Chairman, Surface Oncology, Inc., Sutro Biopharma, Inc., Aileron Therapeutics, Inc., Symic Biomedical, Inc., Aeglea Biotherapeutics, Inc., Protagonist Pty ...
Aug 22, 2017 ... Plaintiffs, v. SAREPTA THERAPEUTICS, INC.; CHRIS GARABEDIAN; EDWARD KAYE,. Defendants, Appellees,. SANDESH MAHATME,. Defendant. APPEALS FROM THE UNITED STATES DISTRICT COURT. FOR THE DISTRICT OF MASSACHUSETTS. [Hon. Indira Talwani, U.S. District Judge]. Before.
SVP, Regulatory Affairs & Qual, 11,500, Derivative/Non-derivative trans. at $14.76 per share. 169,740. 08/03/2017, Edward M. Kaye Director, 16,703, Derivative/Non-derivative trans. at $37.88 per share. 632,709. 08/03/2017, Sandesh Mahatme EVP, CFO & CBO, 6,264, Derivative/Non-derivative trans. at $37.88 per share.
Jul 28, 2017 ... EVP, CFO & CBO Sandesh Mahatme sold 50,000 shares of SRPT stock on 07/20 /2017 at the average price of $41. The price of the stock has decreased by 1.02% since. Directors and Officers Recent Trades: SVP, Regulatory Affairs & Qual Shamim Ruff sold 12,138 shares of SRPT stock on 07/21/2017 at ...
Nov 7, 2017 ... Q3 2017 Sarepta Therapeutics Inc Earnings Call. BOTHELL Nov 7, 2017 ( Thomson StreetEvents) -- Edited Transcript of Sarepta Therapeutics Inc earnings conference call or presentation Wednesday, October 25, 2017 at 8:30:00pm GMT . TEXT version of Transcript.